• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多巴胺激动剂治疗下催乳素分泌性腺瘤的光学显微镜形态计量学

Light microscopical morphometry of prolactin secreting adenomas under treatment with dopamine agonists.

作者信息

Hamester U, Saeger W, Lüdecke D K

机构信息

Department of Pathology, Marienkrankenhaus, Hamburg, FRG.

出版信息

Histol Histopathol. 1987 Apr;2(2):135-42.

PMID:2980713
Abstract

In order to study the light microscopical alterations of pituitary tumours under dopamine agonist treatment, three groups of a total of 18 large or small cell chromophobe adenomas were analysed by light microscopical, immunohistological and morphometrical methods. They were all removed by transsphenoidal surgery. 6 of them were treated preoperatively with dopamine agonists, bromocriptine and/or lisuride, for various periods of time. 8 adenomas remained preoperatively untreated. 4 additional untreated tumors were small cell inactive adenomas for comparison. One case was excluded from the final evaluation of the data because it appeared to be a typical non-responder, clinically as well as histologically. Immunohistological positivity for prolactin was to be found in all cases in various degrees. Clinically active adenomas contained many prolactin positive cells, whereas in inactive adenomas only scattered cells were prolactin positive. The morphometric analysis revealed a reduction of the cytoplasmic area in a statistically significant degree in the group of adenomas under treatment, which explains adequately the shrinkage of the entire adenoma and the reduction of prolactin plasma levels. The morphometric data of treated adenomas resembled those of untreated inactive adenomas.

摘要

为了研究多巴胺激动剂治疗下垂体肿瘤的光镜改变,采用光镜、免疫组织化学和形态计量学方法对三组共18例大细胞或小细胞嫌色性腺瘤进行了分析。所有肿瘤均经蝶窦手术切除。其中6例在术前接受了不同时间段的多巴胺激动剂(溴隐亭和/或麦角乙脲)治疗。8例腺瘤术前未接受治疗。另外4例未治疗的肿瘤为小细胞无功能腺瘤作为对照。有1例因在临床和组织学上均表现为典型的无反应者而被排除在最终数据评估之外。所有病例中均不同程度地发现催乳素免疫组织化学阳性。临床有功能腺瘤含有许多催乳素阳性细胞,而无功能腺瘤中仅有散在的细胞为催乳素阳性。形态计量学分析显示,治疗组腺瘤的细胞质面积在统计学上有显著减少,这充分解释了整个腺瘤的缩小以及血浆催乳素水平的降低。治疗腺瘤的形态计量学数据与未治疗的无功能腺瘤相似。

相似文献

1
Light microscopical morphometry of prolactin secreting adenomas under treatment with dopamine agonists.多巴胺激动剂治疗下催乳素分泌性腺瘤的光学显微镜形态计量学
Histol Histopathol. 1987 Apr;2(2):135-42.
2
Necroses of prolactin-secreting pituitary adenomas under treatment with dopamine agonists: light microscopical and morphometric studies.多巴胺激动剂治疗下催乳素分泌型垂体腺瘤的坏死:光镜及形态计量学研究
Exp Clin Endocrinol. 1988 Sep;92(1):59-68. doi: 10.1055/s-0029-1210782.
3
Ultrastructural morphometry of prolactin secreting adenomas treated with dopamine agonists.多巴胺激动剂治疗的催乳素分泌性腺瘤的超微结构形态计量学
Pathol Res Pract. 1986 Jun;181(3):280-90. doi: 10.1016/S0344-0338(86)80104-2.
4
Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.组织激肽释放酶及溴隐亭对人泌乳素及生长激素分泌型垂体腺瘤的作用。
Agents Actions Suppl. 1992;38 ( Pt 2):175-82.
5
Morphologic changes of prolactin-producing pituitary adenomas after short treatment with dopamine agonists.多巴胺激动剂短期治疗后催乳素分泌型垂体腺瘤的形态学变化
Acta Neuropathol. 2006 Jan;111(1):46-52. doi: 10.1007/s00401-005-1111-8. Epub 2005 Nov 23.
6
Light and electron microscopical morphometry of pituitary adenomas in hyperprolactinemia.高催乳素血症中垂体腺瘤的光镜和电镜形态计量学研究
Pathol Res Pract. 1986 Oct;181(5):544-50. doi: 10.1016/S0344-0338(86)80147-9.
7
[Treatment of prolactinoma with a new dopamine agonist].[新型多巴胺激动剂治疗泌乳素瘤]
Dtsch Med Wochenschr. 1991 Aug 16;116(33):1224-7. doi: 10.1055/s-2008-1063739.
8
Prolactin-secreting adenomas. A light and electron microscopical study.催乳素分泌性腺瘤。光镜与电镜研究。
Arch Pathol. 1975 Dec;99(12):625-33.
9
Giant invasive prolactinoma: a case report and review of nine further cases.巨大侵袭性催乳素瘤:一例报告及另外九例病例回顾
Q J Med. 1990 Mar;74(275):227-38.
10
Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.一名年轻女性在接受溴隐亭治疗后,大泌乳素瘤最初缩小,之后迅速再次增大。
Gynecol Endocrinol. 2005 Jun;20(6):317-21. doi: 10.1080/09513590500098034.

引用本文的文献

1
[Effects of irradiation therapy and inhibiting drugs on the pituitary and its adenomas].[放射治疗及抑制药物对垂体及其腺瘤的影响]
Pathologe. 2006 Feb;27(1):57-60. doi: 10.1007/s00292-005-0809-7.
2
Pituitary tumors: prognostic indicators.垂体肿瘤:预后指标
Endocrine. 2005 Oct;28(1):57-66. doi: 10.1385/ENDO:28:1:057.